Imbruvica and Septic shock - a phase IV clinical study of FDA data
Septic shock is found among people who take Imbruvica, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Imbruvica and have Septic shock. It is created by eHealthMe based on reports of 50,071 people who have side effects when taking Imbruvica from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
50,071 people reported to have side effects when taking Imbruvica.
Among them, 150 people (0.3%) have Septic shock.
What is Imbruvica?
Imbruvica has active ingredients of ibrutinib. It is often used in chronic lymphocytic leukemia (cll). eHealthMe is studying from 50,134 Imbruvica users for its effectiveness, alternative drugs and more.
What is Septic shock?
Septic shock (shock due to blood infection) is found to be associated with 2,933 drugs and 3,061 conditions by eHealthMe.
Number of Imbruvica and Septic shock reports submitted per year:
Time on Imbruvica when people have Septic shock *:
Gender of people who have Septic shock when taking Imbruvica*:
Age of people who have Septic shock when taking Imbruvica *:
Common drugs people take besides Imbruvica *:
Common side effects people have besides Septic shock *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Imbruvica and have Septic shock?Check whether Septic shock is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Septic shock and when was it recovered:
Expand to all the drugs that have ingredients of ibrutinib:
Alternative drugs to, pros and cons of Imbruvica:
- Imbruvica (50,134 reports)
Common Imbruvica side effects:
- Death: 5,356 reports
- Fatigue (feeling of tiredness): 4,151 reports
- Diarrhea: 3,399 reports
- Head injury: 2,818 reports
- Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2,600 reports
- Pneumonia: 2,428 reports
- Weakness: 2,420 reports
- Rashes (redness): 2,329 reports
Browse all side effects of Imbruvica:a b c d e f g h i j k l m n o p q r s t u v w x y z
Septic shock treatments and more:
- Septic shock (44,371 reports)
COVID vaccines that are related to Septic shock:
- Septic shock in Moderna COVID Vaccine
- Septic shock in Pfizer BioNTech Covid Vaccine
- Septic shock in Johnson and Johnson Covid Vaccine
Common drugs associated with Septic shock:
- Prednisone: 4,530 reports
- Methotrexate: 3,597 reports
- Cyclophosphamide: 2,582 reports
- Prednisolone: 2,047 reports
- Cytarabine: 1,896 reports
- Furosemide: 1,845 reports
- Aspirin: 1,740 reports
- Omeprazole: 1,677 reports
- Tacrolimus: 1,492 reports
- Dexamethasone: 1,464 reports
All the drugs that are associated with Septic shock:
- Septic shock (2,933 drugs)
Common conditions associated with Septic shock:
- Rheumatoid arthritis: 2,465 reports
- Multiple myeloma: 2,173 reports
- High blood pressure: 2,171 reports
- Pain: 1,315 reports
- Atrial fibrillation/flutter: 987 reports
- Preventive health care: 962 reports
- Diabetes: 880 reports
All the conditions that are associated with Septic shock:
- Septic shock (3,061 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ibrutinib (the active ingredients of Imbruvica) and Imbruvica (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rasilez and Dengue Fever - now
- Concerta and Diarrhea Aggravated - 2 seconds ago
- Sumatriptan and Glucose Urine Present - 13 seconds ago
- Roxicodone and Lyme Disease - 15 seconds ago
- Paxil and Zide drug interaction - 17 seconds ago
- Nebivolol Hydrochloride and Sevelamer Hydrochloride drug interaction - 23 seconds ago
- Sumatriptan Succinate and Multi-Organ Failure - 26 seconds ago
- How effective is Ritalin for Sleep Disorder? - 28 seconds ago
- Bystolic vs. Plendil - 28 seconds ago
- Cosopt and Scopolamine drug interaction - 28 seconds ago